Tfs Capital Has Increased Pharmathene (PIP) Holding By $1.16 Million; Atomera (ATOM) Sellers Increased By 3.9% Their Shorts

August 27, 2017 - By Marie Mckinney

Atomera (NASDAQ:ATOM) had an increase of 3.9% in short interest. ATOM’s SI was 34,600 shares in August as released by FINRA. Its up 3.9% from 33,300 shares previously. With 14,700 avg volume, 2 days are for Atomera (NASDAQ:ATOM)’s short sellers to cover ATOM’s short positions. The SI to Atomera’s float is 0.39%. The stock decreased 1.57% or $0.07 on August 25, reaching $4.38. About 22,487 shares traded or 5.31% up from the average. Atomera Inc (NASDAQ:ATOM) has 0.00% since August 27, 2016 and is . It has underperformed by 16.70% the S&P500.

Tfs Capital Llc increased Pharmathene Inc (PIP) stake by 566.47% reported in 2016Q4 SEC filing. Tfs Capital Llc acquired 385,044 shares as Pharmathene Inc (PIP)’s stock 0.00%. The Tfs Capital Llc holds 453,016 shares with $1.47 million value, up from 67,972 last quarter. Pharmathene Inc now has $33.47 million valuation. It closed at $2.17 lastly. It is up 0.00% since August 27, 2016 and is . It has underperformed by 16.70% the S&P500.

Tfs Capital Llc decreased Employers Holdings Inc (NYSE:EIG) stake by 12,977 shares to 8,064 valued at $319,000 in 2016Q4. It also reduced Asbury Automotive Group Inc (NYSE:ABG) stake by 12,783 shares and now owns 7,544 shares. Super Micro Computer Inc (NASDAQ:SMCI) was reduced too.

Atomera Incorporated, formerly MEARS Technologies, Inc., is a development-stage company. The company has market cap of $53.26 million. The Firm is engaged in the development, commercialization and licensing of processes and technologies for the semiconductor industry. It currently has negative earnings. The Company’s technology, named Mears Silicon Technology , is a thin film of reengineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick.